Ganga Care Hospital Ltd
Nagpur multi-speciality hospital, 74% owned by CARE Hospitals' Quality CARE India — a small, thinly traded regional healthcare stock.
Market cap
₹379.62 Cr
1.19 Cr shares
P/E ratio
25.32
Sector average 45
Book value
₹90.08
P/B 3.55
1-year return
+0.00%
52w ₹320 – ₹320
Currently 0% of the way through its 52-week range.
Indicative price history
1Y change
+0.00% ₹320 → ₹320
52-week band in this window: ₹320.00 – ₹320.00. Weekly indicative marks, not exchange-traded prices.
Key highlights
- Tertiary multi-speciality hospital in Nagpur under the CARE Hospitals brand; QCIL holds 74.13%.
- Share capital ₹11.86 Cr (1.186 Cr shares of ₹10); dealer rate ₹320 values the company near ₹380 Cr.
- Parent is merging into Aster DM Quality Care, one of India's largest hospital groups.
About Ganga Care
Ganga Care Hospital Limited runs the Ganga CARE Hospital at Panchsheel Square on Wardha Road, Nagpur — a tertiary multi-speciality hospital offering cardiac sciences, neurosciences, orthopaedics, oncology, critical care and transplant services to the Vidarbha region. The company was incorporated on 25 January 2005 as a public limited company and is registered with the RoC Mumbai.
Quality CARE India Limited (QCIL), the holding company of the CARE Hospitals chain, owns 74.13% of the equity; the balance is spread across Nagpur doctors, promoters of the original Ganga hospital and other investors, which is where the unlisted float comes from. QCIL itself was acquired by Blackstone in 2023 and is being merged with Aster DM Healthcare to create Aster DM Quality Care, one of India's largest hospital groups.
The share capital is ₹11.86 Cr (1.186 Cr shares of ₹10), so at the dealer rate of ₹320 the whole company is valued at about ₹380 Cr. Dealers list the stock at a flat price with no recent movement, which reflects the small float rather than a live two-way market.
Figures preliminary; verify from MCA filings. Revenue and profit lines on this page are minimal estimates built from the paid-up capital, the hospital's scale and provider summaries (FY22 operating revenue was reported in the ₹1–100 Cr band); they are not audited numbers. The company's FY25 annual report has been published on the CARE Hospitals website and should be used to replace them.
Where the revenue comes from
- In-patient services70%
Cardiac, neuro, ortho, oncology and critical-care admissions; estimate
- Out-patient, diagnostics & pharmacy30%
OPD consultations, lab, imaging and in-house pharmacy; estimate
Products & services
Cardiac sciences
Cardiology, cardiac surgery and cath-lab procedures — the hospital's original speciality.
Neuro, ortho and oncology
Neurosurgery, joint replacement, spine and cancer care for the Vidarbha catchment.
Critical care & transplant
ICU beds, emergency and kidney transplant programme.
What works
- • Part of the CARE Hospitals network (Quality CARE India, 74.13%), giving access to group procurement, clinical protocols, brand and management depth.
- • Established tertiary-care position in Nagpur, a growing referral hub for central India with limited corporate hospital competition.
- • Debt-light balance sheet backed by a well-capitalised parent that is itself being folded into Aster DM Quality Care.
What to watch
- • Very small float (about 26% non-promoter) and a single-hospital business — dealer quotes are flat and exits can take time.
- • Financials on this page are estimates; the actual margins of a single regional hospital can be thin and volatile.
- • Minority holders depend on the parent's plans; a squeeze-out, merger or capital reduction by QCIL/Aster could set the exit price rather than the market.
- • No dividend record or investor communication is available to unlisted holders beyond statutory AGM notices.